Merck的Q3收入损失估计,但公司提高了股息,投资者的兴趣上升。 Merck's Q3 earnings missed estimates, but the company boosted its dividend and saw rising investor interest.

Merck & Co.报告第三季度收入为每股1.94美元,略低于2.08美元的估计数,同时保持强劲的财政健康,股本回报率为44.54%,净利润率为29.63%。 Merck & Co. reported third-quarter earnings of $1.94 per share, slightly below the $2.08 estimate, while maintaining strong financial health with a 44.54% return on equity and 29.63% net margin. 公司将季度红利提高到0.85美元,收益率为3.2%,而且机构投资者增加了股份,包括稳定伙伴有限责任公司和查尔斯·施瓦布投资管理公司。 The company raised its quarterly dividend to $0.85, yielding 3.2%, and saw institutional investors increase their stakes, including Stablepoint Partners LLC and Charles Schwab Investment Management. 以Keyturda和Gardasil著称的Merck, 市场上限为2665.4亿美元, 交易额为107.39美元, Merck, known for Keytruda and Gardasil, has a market cap of $266.54 billion, trades at $107.39, and holds a consensus "Hold" rating with a $114.20 target.